Investor
The company plans to invest the funds in its platform’s technology and capabilities, and to make new hires.
The company is looking to use this money to expand its reach and build out its product line.
It allows people to get medications and lab tests delivered to their homes, and to access personal care plans and specialists.
The company plans to use the new funds to grow its payer and employer markets.
The company is looking to use these tools to help its EU expansion.
The company created a cloud-based platform that harnesses the power of brain data.
The MSK care company said the computer vision tech will allow users to measure a patient’s movement ability and personalize their care.
Human Capital and Greenoaks Capital led the latest round, according to Insider’s reporting.
Also: Caresyntax adds $30 million to its Series C, and SafelyYou closed a $19.5 million Series A funding round.
The startup will use the funds to expand further into secondary care.